ICOS and neoplasm: Moreover, the expression of immune checkpoints, such as CD137 (4-1BB), inducible co-stimulator (ICOS), T cell immunoglobulin and mucin domain 3 (TIM-3) changed in the tumor microenvironment could affect tumor progression [13].